Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US7235653B2 · kind B2 · utility
112Cited by
21References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2003 |
| Grant date | Jun 26, 2007 |
| Priority date | — |
| Expiry date | Jun 23, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for the treatment of asthma with oligonucleotides which specifically hybridize with nucleic acids encoding B7 proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.